Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ·Healthcare·Biotechnology
$107.64
-4.09%
Mkt Cap $6.96B
Analyst Ratings
Buy
20
Hold
0
Sell
0
Price Target (49 analysts)
$146.00
Range $118.00 – $185.00
Implied Upside
+35.6%
Consensus $146.00 vs current $107.64